Xarelto and Severe Internal Bleeding

 prescription bottles

What is Xarelto?

Xarelto is a blood thinner, manufactured by Janssen Pharmaceutical. It has been prescribed to prevent blood clots in patients who suffer from irregular heartbeats, blood clots deep within the body, blood clots in the lungs, stroke and patients who have recently had knee or hip replacement surgery.

It’s typically prescribed as an alternative to Warfarin, a blood thinner that’s been in use since 1954.

Xarelto Side Effects

The most serious side effect caused by Xarelto is sever internal bleeding, potentially resulting to death. There is no known antidote to reverse the internal bleeding caused by Xarelto.

While Xarelto’s counterpart, Warfarin, can be treated by administering Vitamin K during a bleeding episode, doctors can only wait while Xarelto is flushed out of the patient’s body when a severe there is uncontrolled bleeding.

Even the use of dialysis is insufficient in reversing the bleeding caused by Xarelto, often resulting in fatal hemorrhages.

Common Side Effects:

  • Low blood pressure
  • Nausea and vomiting
  • Muscle pain
  • Edema or swelling
  • Bloody nose

Serious Side Effects:

  • Stroke
  • Spinal Hemorrhage
  • Epidural Hemorrhage
  • Cerebral Hemorrhage
  • Gastrointestinal Hemorrhage
  • Blood clots

Signs of Internal Bleeding:

  • Extreme fatigue or dizziness
  • Pale skin
  • Abdominal swelling
  • Unexplained bruising
  • Rectal or urinary bleeding
  • Eye or nose bleeding

Xarelto Recall Information

There has not been a recall of Xarelto related to internal bleeding.

However, in  2014 the FDA required Xarelto makers to add warnings  and update its “black box” warning, the most urgent type. The language included:

  • Lack of an antidote to treat excessive bleeding due to the blood-thinning effects of Xarelto
  • Incomplete data regarding Xarelto’s effects on who have heart valves
  • Thrombotic events as a result of ending prescribed use prematurely

Xarelto Lawsuit

The lawsuit involving Xarelto claims the manufacturer failed to warn doctors and patients that the drug could cause excessive internal bleeding, and that a substitute medication was just as effective at reducing blood clots but without the danger of incurable bleeding.

Xarelto cases argue the following:

  • Manufacturers failed to provide adequate warnings about the risks of taking Xarelto
  • Manufactures failed to release the drug with an antidote, meaning that once a bleed develops, doctors may have no way to stop the bleed
  • They used deceptive marketing practices which did not take into account patient safety

More than 8,000 Xarelto lawsuits are awaiting trial. Similar lawsuits against blood thinner Pradaxa resulted in a $650 million settlement.

Patients are family members of patients who have suffered serious complications from taking Xarelto may be eligible to collect financial compensation for:

  • Current and future medical expenses
  • Current and future lost wages
  • Medical expenses not covered by insurance
  • Pain and suffering
  • Loss of consortium (future family benefits)

 How Will a Settlement Be Determined?

The following are some of the common factors that may be considered by a jury and will be taken into consideration during negotiations:

  • The extent and duration of injuries from Xarelto
  • Effects that the injuries had on the physical and mental health of the patient
  • Pain and suffering
  • Past and future medical expenses caused by Xarelto use
  • Lost wages
  • The losses suffered by family members in Xarelto wrongful death cases

How Much Time Do I Have to File?

If you or a loved one suffered serious bleeding problems while taking Xarelto, you could be eligible for compensation. You have a limited timeframe to file a claim and if you fail to file within typically two years, you could lose your right to file a claim.

The statute of limitations for pharmaceutical product liability claims, typically two years, varies from state to state. In most cases, the time does not begin running until the injured person discovers, or should have discovered, the injury caused by the dangerous drug.